Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Gland Pharma IPO.
November 9, 2020 2:30:00 AM
Gland Pharma is one of the biggest pharma IPOs. The company has a focus on complex injectables which has high entry barriers and strategic partnerships to penetrate new markets like China ...
Published by : MintNovember 4, 2020 9:42:00 AM
The IPO of Hyderabad-based Gland Pharma will open on November 9 and close on November 11. The company plans to raise up to ?1,250 crore through issue of fresh equity shares up to 34.8 lakh.
Published by : Business Insider IndiaJune 20, 2024 7:12:00 PM
The company bought Gland Pharma for around Rs 8,500 crore in 2016, sold shares to the public (IPO) at a valuation of Rs 24,000 crore in 2020 and is now paring its stake at a market capitalisation of ...
Published by : moneycontrol.comNovember 9, 2020 10:55:00 AM
The recent geopolitical tension between India and China remains a big risk factor, and may not play out well for Gland Pharma. The ?6,500 IPO of Hyderabad-based Gland Pharma is now open for ...
Published by : Business Insider IndiaNovember 18, 2020 6:27:00 PM
The Initial Public Offer (IPO) of Rs 6500 cr of Gland Pharma received good response from the investors. The issue was subscribed by 2.06 times. The share of retail investors got subscribed 24%, while ...
Published by : Zee BusinessNovember 4, 2020 2:30:00 AM
Around 6 million shares of Gland Pharma, which were held by 10 companies set up by Satyam founder B. Ramalinga Raju, were to be locked-in for a period of 12 months after the IPO as per norms of ...
Published by : MintJune 19, 2024 7:52:00 PM
Fosun Pharma, a promoter of Gland Pharma, divested a 6% stake for Rs 1,754 crore via an open market transaction. This reduced its shareholding from 57.86% to 51.86%. UBS Principal Capital Asia ...
Published by : devdiscourseJune 20, 2024 1:02:00 PM
Fosun Pharma Industrial Pte will sell its stake in India�s Gland Pharma Ltd in tranches after failing to sell it all at once. According to the terms of the agreement, the business will sell 5% ...
Published by : India InfolineNovember 20, 2020 8:35:00 PM
Gland Pharma has been listed today and the stock was trading around Rs 1806.95 on NSE at 10:10 pm, up by over 5.6 per cent. Zee Business Managing Editor Anil Singhvi explains what investors can look ...
Published by : Zee BusinessJune 26, 2024 3:30:00 AM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Published by : MorningstarMay 28, 2024 4:00:00 AM
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment.
Published by : India InfolineJune 18, 2024 10:18:00 PM
Telix Pharmaceuticals Limited (OTCPK:TLPPF, TLX) has already done well to advance a diagnostic for patients with Illucix diagnostic, which was approved by the FDA to help infer patients with PSMA ...
Published by : Seeking AlphaThe IPO Shares of Gland Pharma Limited IPO are proposed to list on Friday, November 20, 2020 at BSE, NSE. The public issue of Gland Pharma IPO was opened on Nov 9, 2020 and closed for subscription on Nov 11, 2020. Gland Pharma IPO Listing Date and Information:
| Listing Date | Friday, November 20, 2020 |
| BSE Script Code | 543245 |
| NSE Symbol | GLAND |
| Listing In | |
| ISIN | INE068V01023 |
| Issue Price | [.] |
| Face Value | Rs 1 Per Equity Share |
The allotment status of Gland Pharma Limited IPO is now available online. The public issue of Gland Pharma IPO was open on Nov 9, 2020 and closed for subscription on Nov 11, 2020. The equity shares of the company to be list at BSE, NSE.
Gland Pharma Limited is entering in the capital market with an IPO of [.] Equity Shares of Rs 1 aggregating up to Rs [.] Crore. The price for the issue has been set at Rs 1490 - Rs 1500 Per Equity Share.
Gland Pharma Ltd, the Hyderabad-based company is one of the fastest-growing generic injectable companies. It manufactures a diversified range of high-quality complex injectables. The company offers products like sterile injectables, oncology, and ophthalmics, complex injectables (peptides, suspensions, hormonal products, long-acting injectables), NCE-1s, First-to-File products, etc.
The issue opens on Nov 9, 2020 and closes for subscription on Nov 11, 2020. The equity shares of the company to be list at BSE, NSE.
The issue of Gland Pharma Limited opens on Nov 9, 2020 and closes for subscription on Nov 11, 2020. The equity shares of the company to be list at BSE, NSE. The price for the issue has been set at Rs 1490 - Rs 1500 Per Equity Share.
The Gland Pharma IPO is proposed to open on November 9, 2020. The IPO application ends on November 11, 2020.
Retail investors can apply in the retail or non-institutional investor category from November 9, 2020 to November 11, 2020. The Gland Pharma IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Gland Pharma IPO will open for subscription on November 9, 2020. The public issue will close on November 11, 2020.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
